Retail Trade cocokara fine, Inc. Business Summary
cocokara fine, Inc. engages in the planning and management of its group companies that are involved in drugstore chain operations. It operates through the following segments: Drug Store and Pharmacy Business, Nursing Care Business, and Others. The Drug Store and Pharmacy Business segment deals with the retail distribution of pharmaceutical products, cosmetics, and household items. The Nursing Care Business segment operates nursing care facilities and offers home-care services. The Others segment covers wholesale, e-commerce and international businesses. The company was founded on April 1, 2008 and is headquartered in Yokohama, Japan.
Financial Highlights
Mar 2020
JPY USD Revenue 403,875M 3,714.62M Gross Profit 108,098M 994.22M Operating income 13,338M 122.67M Income before tax 12,971M 119.30M Net income 8,270M 76.06M EBITDA 17,863M 164.29M Diluted EPS 344.05 3.16 Dividends Per Share 92 0.84 Total Assets 208,298M 1,929.48M Total liabilities 68,642M 635.83M Total equity 139,653M 1,293.62M Operating cash flow 12,919M 118.82M Currency in JPY Currency in USD
Historical Data Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Revenue
373,275M
377,203M
390,963M
400,559M
403,875M
Gross Profit
92,774M
93,564M
101,205M
104,914M
108,098M
Operating income
11,119M
10,140M
13,665M
12,905M
13,338M
Income before tax
11,705M
11,339M
14,638M
13,795M
12,971M
Net income
6,927M
7,037M
9,067M
9,158M
8,270M
EBITDA
15,022M
14,162M
17,641M
16,870M
17,863M
Diluted EPS
279.32
286.79
376.38
381.24
344.05
Dividends Per Share
70
70
73
76
92
Total Assets
142,404M
146,963M
158,177M
172,727M
208,298M
Total liabilities
64,449M
63,723M
70,365M
77,644M
68,642M
Total equity
77,955M
83,237M
87,810M
95,081M
139,653M
Operating cash flow
17,809M
9,381M
17,117M
9,388M
12,919M
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Revenue
3,108.44M
3,483.34M
3,527.51M
3,612.06M
3,714.62M
Gross Profit
772.57M
864.03M
913.13M
946.06M
994.22M
Operating income
92.59M
93.63M
123.29M
116.37M
122.67M
Income before tax
97.47M
104.71M
132.07M
124.39M
119.30M
Net income
57.68M
64.98M
81.80M
82.58M
76.06M
EBITDA
125.09M
130.78M
159.16M
152.12M
164.29M
Diluted EPS
2.32
2.64
3.39
3.43
3.16
Dividends Per Share
0.58
0.64
0.65
0.68
0.84
Total Assets
1,266.99M
1,318.88M
1,487.32M
1,560.52M
1,929.48M
Total liabilities
573.41M
571.86M
661.63M
701.48M
635.83M
Total equity
693.58M
746.98M
825.66M
859.02M
1,293.62M
Operating cash flow
148.30M
86.63M
154.44M
84.65M
118.82M
Valuation Measures
Mar 2020
PER 16.30 ROA 4.34% ROE 7.04% Operating margin 3.30% Profit margin 2.04%
Key executives
President & Representative Director:
Atsushi Tsukamoto
Executive Officer & Manager-Information Technology:
Yasuyuki Oike
Senior Manager-Compliance & Manager-Legal Affairs:
Masafumi Morita
Director, VP, GM-Administration & Manager-Strategy:
Tsuyoshi Yamamoto
Executive Officer & Manager-Internal Audit Office:
Ryoichi Wachi Shareholders
Matsumotokiyoshi Holdings Co., Ltd. (19.1%)
Seishin Kagaku Kai (5.3%)
cocokara fine, Inc. (4.3%)
Pictet Asset Management Ltd. (3.2%)
Cocokara Fine Holdings Employee Stock Ownership Plan (2.8%)
SEGAMI FAMILY (2.6%)
Nomura Asset Management Co., Ltd. (2.3%)
Daiichi Sankyo Co., Ltd. (1.9%)
SAITO MAYUMI (1.8%)
Baillie Gifford & Co. (1.8%)
Related Companies
Yakuho Shoji YK
Flight YK
Koishikawa Pharmacy KK
K S YK
Cocokara Fine Employee Incentive Plan
Senior Cosmos Co., Ltd.
Toho Chozai YK
cocokarafine soleil Co. Ltd.
Yamamoto Service KK
Shanghai Cocokara Fine, Inc.
Cocokara Fine Next Co., Ltd.
cocokarafine associe, Inc.
cocokara fine OEC, Inc.
Cocokara fine Healthcare, Inc.
I System KK (Yamaguchi)
Kojido Corp.
Kusuri No Ebina YK
Finecare, Inc.
Kodama Co., Ltd. (Niigata)
Reha Works YK
Medical Index YK
Aianju KK
SO Pharmaceutical Corp.
Cocokara Fine Holdings Employee Stock Ownership Plan
Kotobuki YK
Koshi Yakkyoku YK
Iwasaki Kokendo KK
Suzuran Pharmacy KK
Takara Care Co. Ltd.
Segami Medics Co. Ltd.
Competitors
Welcia Holdings Co., Ltd.
Create SD Holdings Co., Ltd.
TSURUHA Holdings, Inc.
Pharmarise Holdings Corp.
Medical System Network Co., Ltd.
COSMOS Pharmaceutical Corporation
KUSURI NO AOKI HOLDINGS CO.,LTD.
Sugi Holdings Co., Ltd.
Sundrug Co., Ltd.
Matsumotokiyoshi Holdings Co., Ltd.
Nihon Chouzai Co., Ltd.
Ain Holdings Inc.
Qol Holdings Co., Ltd.
Copyright © 2020 FactSet Research Systems Inc. All rights reserved.
Last Updated on 28 Oct, 2020
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.
Celebrate our next chapter Find out more
By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our
Cookie Policy
to learn how you can update your cookie settings.
Accept & Continue
Close
